Is there such a thing as a flawless launch? Can we truly anticipate and mitigate all potential scenarios despite extensive pre-planning that could sometime span years? How to make the perfect trade-offs? How to achieve quick wins while embracing the concept of failing faster with a mixture of agility, openness, and resilience? My journey has afforded me the opportunity to lead both global and regional launches, offering a diverse array of insights. In this intricate process, crafting a message that resonates with Key Opinion Leaders (KOLs) emphasizing the benefits for patients, serve as the crucial entry point. Incentivizing the core launch team and continuous alignment with secondary and tertiary stakeholders are paramount.
Sarika Sharma的动态
最相关的动态
-
We are very much looking forward to getting the community back together this fall for #ExecutiveDecisionMaking 2024. Review the newly release preliminary agendas and take advantage of early savings and secure your spot to join seasoned bio pharma strategic and operational leaders to delve into new approaches and share best practices. #portfoliomanagement #resourcemanagement
Connecting Biopharma Leaders to Advance Pharmaceutical R&D in Clinical Trial Operations, Alliance Management, Data Science & Informatics, Portfolio & Resource Management
I am pleased to announce the Preliminary Agena is now available for CHI's 21st Annual Executive Decision Making for Pharma & Biotech conference. Program & Portfolio Management—a 2-day meeting focused on driving optimized portfolio insights, prioritization, and decision-making is taking place October 8-9, 2024, in Boston. Strategic Resource Management returns to Boston October 9-10. The meeting hones in on the tools and strategies to enhance R&D productivity, resource planning and forecasting, and capacity management. Take advantage of early savings and secure your spot to join seasoned biopharma strategic decision makers. Please review the preliminary agenda here:? https://bit.ly/3Qk5qFU And thank you to oru esteemed faculty: Helen Merianos Michelle Shogren Greg Wayne, Ph.D., MBA Caroline Dewing Charles Naaman Charles Persinger Mike Myers Christopher Larson Stephen Cho Elayne K. Joe Stalder Michael Ferrante Stuart Fort Sabine Lenders Thomas De Vis Sean Gallagher Chris Kaster Alexander Rucci #PortfolioManagement #ResourceManagement ?#ExecutiveDecisionMaking
Executive Decision Making for Pharma & Biotech | October 8-10, 2024 | Boston
executivedecisionmaking.com
要查看或添加评论,请登录
-
Looking forward to speaking at CHI's 21st Annual Executive Decision Making for Pharma and Biotech conference. Join my session to: Unlock the Power of Change: Elevate Your Leadership Journey As a forward-thinking leader, you wield the power to orchestrate transformative change within your organization. Yet, amidst the dynamic landscape of progress, do you possess the essential toolkit to navigate inevitable challenges and conflicts, ensuring collaboration prevails over escalation? Join us for an engaging session where you'll uncover not only the five critical pillars of effective change management but also strategies for adept conflict resolution. Gain invaluable insights to steer your organization towards a future of innovation, resilience, and sustainable growth. Seize this transformative opportunity to elevate your leadership prowess and drive impactful change. #leadership #innovation #change #changemanagement #conflictresolution #decisionmaking Bridget Kotelly Micah Lieberman
Connecting Biopharma Leaders to Advance Pharmaceutical R&D in Clinical Trial Operations, Alliance Management, Data Science & Informatics, Portfolio & Resource Management
I am pleased to announce the Preliminary Agena is now available for CHI's 21st Annual Executive Decision Making for Pharma & Biotech conference. Program & Portfolio Management—a 2-day meeting focused on driving optimized portfolio insights, prioritization, and decision-making is taking place October 8-9, 2024, in Boston. Strategic Resource Management returns to Boston October 9-10. The meeting hones in on the tools and strategies to enhance R&D productivity, resource planning and forecasting, and capacity management. Take advantage of early savings and secure your spot to join seasoned biopharma strategic decision makers. Please review the preliminary agenda here:? https://bit.ly/3Qk5qFU And thank you to oru esteemed faculty: Helen Merianos Michelle Shogren Greg Wayne, Ph.D., MBA Caroline Dewing Charles Naaman Charles Persinger Mike Myers Christopher Larson Stephen Cho Elayne K. Joe Stalder Michael Ferrante Stuart Fort Sabine Lenders Thomas De Vis Sean Gallagher Chris Kaster Alexander Rucci #PortfolioManagement #ResourceManagement ?#ExecutiveDecisionMaking
Executive Decision Making for Pharma & Biotech | October 8-10, 2024 | Boston
executivedecisionmaking.com
要查看或添加评论,请登录
-
Dear colleagues and friends, Today, with mixed feelings, I say goodbye to this great pharmaceutical company that is Roche, which has been my home for the last seven years. During this time, we have made significant progress in the field of neuroscience, and I want to share some of our most notable achievements. **We managed to position ourselves as leaders in neuroscience and low-prevalence diseases, making a difference in the lives of patients, their families and health systems, and that is something we can all be proud of. **We created a great high-performance team that made a difference nationally and internationally. **We generated constant innovation from our ways of working, applying agile methodologies to our medical-scientific events. **Positive Action Leadership: Leadership is not just about titles or hierarchies. It's about inspiring others, making brave decisions and acting with integrity. I thank each member of my team for his daily leadership, for his support, and for her commitment to our mission. **Strategic collaborations: we established various strategic alliances with world-renowned doctors and institutions. **Global impact: we managed to position Mexico and LATAM on the global stage through our work in research, training and medical-scientific events. **Continuous professional development: I always promoted the continuous learning and personal improvement of each team member. I cannot leave without expressing my deep gratitude. Thank you to everyone who has been part of my journey here. Every conversation, every challenge and every smile have left an indelible mark on my heart. In my next chapter, I will continue to explore the frontiers of science and imagination. I hope our paths cross again in the future. With gratitude and admiration, Carlos Pla Casamitjana
要查看或添加评论,请登录
-
The rapid shift to a digital-first world has transformed the way life sciences companies engage and educate HCPs, patients and distributors. So, how are leading pharma, biotech and med device companies confronting this challenge? Download the report, “2023 Digital Engagement Benchmarks: Life Sciences,” to understand the current state of digital engagement based on thousands of digital experiences created and delivered by leading life sciences brands to audiences across the globe in 2022.
2023 Digital Engagement Benchmarks: Life Sciences
要查看或添加评论,请登录
-
When it comes to AI and medical affairs' evolving role in the life sciences, the real winners will be the early adopters of this technology and practices who are agile enough to make changes as new information becomes available. To get an early leg-up on your AI adoption, make sure to attend our upcoming webinar on June 25. The Envision and panel experts will go beyond the theoretical, offering a concrete vision of how AI can redefine every facet of medical work, creating a more efficient and effective pharmaceutical environment! https://lnkd.in/dKjvQS2K
Join us for our inspirational webinar, “Medical, reimagined:?How technology-driven insights can help us rethink strategy and execution.” Paul Simms (Moderator)?will lead the conversation featuring industry leaders?Kate Bradford, Alexion, Luca Dezzani, Johnson & Johnson, Dr. Goran Martinovic, Boehringer Ingelheim, and Jim Streeter, Envision Pharma Group on how we take a new look at the responsibilities and roles within medical affairs – including evidence generation, KOL engagement, information dissemination, and authentic HCP engagement – and reimagine a systems-based rethink of how it will operate several years from today. Register today and learn more on June 25 ?? https://lnkd.in/dKjvQS2K
要查看或添加评论,请登录
-
It was rewarding to be part of the process of sharing Denise’s story. Learning how her coach, Glauber, taught her the value of focus and perseverance truly inspired me! With this mindset, Denise has driven impactful campaigns that helped Sanofi regain market share in generics, making healthcare more accessible to patients. Her story is a powerful reminder of resilience in action. How do you push through challenges? Discover Denise’s full story on our careers site! #SanofiStories #ignitingpotential
Denise Mello Story.mp4
要查看或添加评论,请登录
-
When communicating big announcements or progress, it can be tempting to lead with facts and numbers. While we're all for sharing relevant details, it's so much more impactful within the context of storytelling. That's what we aimed to do with this Novo Nordisk piece announcing their facility expansion in Clayton, NC. We partnered with Novo to combine not only the practical measures around their growth but the broader 'why' behind it. By sharing details wrapped in storytelling and practical renderings surrounded by meaningful footage, it helps the viewer recognize that the growth is more than just a bigger footprint; it's a bigger impact in the lives of individuals. #CreativeVideoAgency #VideoProduction #Storytelling Economic Development Partnership of North Carolina (EDPNC) Check out the video in the article linked below: https://lnkd.in/e-FEvtpg
Building the future for patients?
novonordisk-us.com
要查看或添加评论,请登录
-
One thing I’ve learned over the years from working in large pharma to leading startups is that real success comes from collaboration. When R&D, clinical, and commercial teams are truly aligned, we can bring the best out of our people, our products and make a real difference for patients. I will be sharing more about this today at Fierce Life Sciences Events New Product Planning Summit on a panel discussing: “Successful Collaboration Strategies Across R&D, Clinical, and Commercial Teams.” Throughout my career, I’ve seen how breaking down silos and building strong cross-functional relationships can lead to faster, more innovative product development. It’s all about creating a culture where collaboration isn’t just a goal—it’s a daily practice. I’ll be joined by some fantastic panelists: Erica Paine, VP of Value & Market Access, Chiesi, Susan Nemetz, Founder & CEO of Corval, Cathi Ahearn, SVP of Worldwide Commercial Portfolio Strategy at Bristol Myers Squibb, and Josh Meidenbauer, Senior Director of New Product Planning at Intellia Therapeutics. We’ll dive into how to improve communication between teams, share real-world examples of what’s worked, and discuss why getting everyone on the same page early on is key to moving assets forward smoothly. If you’re at the summit, I’d love to catch up and exchange ideas on how we can keep pushing forward through strong collaboration. Hope to see you there! #fiercelifesciences #newproductplanningsummit https://lnkd.in/ejZSiAqs
要查看或添加评论,请登录
-
?? Strategic partnerships can make or break the future of pharma and biotech innovation. Join Alexandra Procak, Associate Director, Portfolio Management, Corporate Strategy, Astellas Pharma, Christopher Vandepas, Director Portfolio Program Management, Guardant Health, and Chris Knight, Director Program Management, Formation Bio, Parag Jog, PhD, MBA, PMP, Director, Portfolio Program Management, AbbVie, Nick Fingland, PhD, PMP, Senior Director, Strategy Realization Office, BD as they explore the art of strategy formulation and alignment. Whether you're navigating alliances between large pharma and small biotech or merging cultures and visions, this panel discussion will provide key insights for success. Discover how to forge powerful alliances and drive your organization’s future forward. Don’t miss this chance to shape your strategy—register now! https://lnkd.in/dNtaVnvZ #Portfolio2024 #LasVegas #StrategyFormulation #PharmaAlliances #PortfolioManagement #BiotechPartnerships
要查看或添加评论,请登录
Enabling Career and Business Growth through proven LinkedIn Strategies and Diplomatic Networking.
7 个月Flawless launch is probably an illusion Sarika Sharma